Invent Medic Sweden AB (XSAT:IMS) GF Score : 27/100 (As of Dec. 15, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Invent Medic Sweden AB GF Score?

Invent Medic Sweden AB has the GF Score of 27, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 2/10
2. Profitability Rank : 3/10
3. Growth Rank : 5/10
4. GF Value Rank : 0/10
5. Momentum Rank : 0/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Invent Medic Sweden AB might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Invent Medic Sweden AB's GF Score

For the Medical Devices subindustry, Invent Medic Sweden AB's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Invent Medic Sweden AB's GF Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Invent Medic Sweden AB's GF Score distribution charts can be found below:

* The bar in red indicates where Invent Medic Sweden AB's GF Score falls into.

Invent Medic Sweden AB (XSAT:IMS) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score	Performance Potential and All-in-One Screener Examples ⁽¹⁾
91 - 100	Highest outperformance potential
81 - 90	Good outperformance potential
71 - 80	Likely to have average performance
51 - 70	Poor future performance potential
0 - 50	Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Invent Medic Sweden AB GF Score Related Terms

Thank you for viewing the detailed overview of Invent Medic Sweden AB's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Invent Medic Sweden AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Invent Medic Sweden AB (XSAT:IMS) » Definitions » GF Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

Nytenkargatan 4, Lund, SWE, 223 63

Website

http://www.inventmedic.com

Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.

Invent Medic Sweden AB Headlines

From GuruFocus

Weekly Insider Sells Highlight: IMS, NOW, BMY, EA

By James Xiao James Xiao • 08-11-2015

5 Companies Reach 52-Week Highs

By yifan900 yifan900 • 02-13-2018

Healthcare Informatics: A Value Investor's Perspective

By Thomas Macpherson Thomas Macpherson • 10-23-2015

Well-Known Companies Reach 52 Week Highs

By yifan900 yifan900 • 10-11-2016

The Big 3: Larry Robbins' Top 2nd-Quarter Buys

By James Li James Li • 08-16-2016